Literature DB >> 21683301

Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.

Makoto Naganuma1, Reiko Kunisaki, Naoki Yoshimura, Masakazu Nagahori, Hisae Yamamoto, Hideaki Kimura, Minako Sako, Takaaki Kawaguchi, Masakazu Takazoe, Shojiro Yamamoto, Toshiyuki Matsui, Toshifumi Hibi, Mamoru Watanabe.   

Abstract

BACKGROUND: Neither conceptions and pregnancy outcomes nor the safety of medications for childbearing inflammatory bowel disease (IBD) patients has been investigated in Asia. The aim of this study is to analyse conception and pregnancy outcomes of Japanese female IBD patients.
METHODS: We conducted a retrospective cohort study of pregnant IBD patients at 6 institutions. The incidences of abortion, Caesarean delivery, low birth weight (LBW) (<2500g), and congenital malformation were analysed in these patients. Risk factors associated with adverse outcomes in IBD patients were also assessed.
RESULTS: A total of 325 patients experienced 534 conceptions. Among these, 303 conceptions (57%) were observed during/after disease onset. Although conceptions and pregnancy outcomes after disease onset were comparable to the observed levels prior to disease onset in UC patients, the incidences of spontaneous abortion (OR 5.3; 95%CI 1.1-25.0) and Caesarean delivery (OR 4.8; 95%CI 1.5-15.0) were significantly higher in Crohn's disease (CD) patients whose conceptions occurred after disease onset compared to CD patients whose conceptions occurred before disease onset. The incidences of spontaneous abortion, LBW, and Caesarean delivery were higher in CD patients who had a history of surgery for perianal lesions than in those who did not have perianal lesions or who had ulcerative colitis (UC). In the IBD patients studied after disease onset, independent risk factors for spontaneous abortions included a history of previous treatment for sterility (OR 2.9; 95%CI 1.2-7.0). Independent risk factors for Caesarean operation (OR 4.1, 95% CI: 1.7-10.1) and LBW (OR 3.5, 95% CI: 1.3-9.1) included a history of bowel resection for the treatment of IBD. Congenital malformation was not associated with the factors of type of disease, smoking, and previous surgery.
CONCLUSION: In Japanese UC patients, conception and pregnancy outcomes after disease onset were comparable to the outcomes observed prior to disease onset, whereas CD appeared to be associated with adverse outcomes. Caesarean operation and LBW were more frequently observed in CD patients who had a history of surgery for perianal lesions and bowel resection.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683301     DOI: 10.1016/j.crohns.2011.02.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  15 in total

1.  Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Miriam J Haviland; Michele R Hacker; Scott A Shainker; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2017-05       Impact factor: 5.325

2.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

3.  A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease.

Authors:  Makoto Naganuma; Reiko Kunisaki; Naoki Yoshimura; Yoshiaki Takeuchi; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2012-10-05       Impact factor: 7.527

4.  Extent of disease is a major outcome predictor in patients with ulcerative colitis and pregnancy.

Authors:  Amarender Puri; Vaishali Bharadwaj; Sanjeev Sachdeva
Journal:  Indian J Gastroenterol       Date:  2015-04-19

Review 5.  Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Authors:  Hiroshi Nakase; Motoi Uchino; Shinichiro Shinzaki; Minoru Matsuura; Katsuyoshi Matsuoka; Taku Kobayashi; Masayuki Saruta; Fumihito Hirai; Keisuke Hata; Sakiko Hiraoka; Motohiro Esaki; Ken Sugimoto; Toshimitsu Fuji; Kenji Watanabe; Shiro Nakamura; Nagamu Inoue; Toshiyuki Itoh; Makoto Naganuma; Tadakazu Hisamatsu; Mamoru Watanabe; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-04-22       Impact factor: 7.527

Review 6.  Immunogenetic contributions to recurrent pregnancy loss.

Authors:  Frances Grimstad; Sacha Krieg
Journal:  J Assist Reprod Genet       Date:  2016-05-12       Impact factor: 3.357

Review 7.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.

Authors:  Ole Haagen Nielsen; Edward V Loftus; Tine Jess
Journal:  BMC Med       Date:  2013-07-31       Impact factor: 8.775

8.  Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan.

Authors:  Shunsuke Komoto; Satoshi Motoya; Yuji Nishiwaki; Toshiyuki Matsui; Reiko Kunisaki; Katsuyoshi Matsuoka; Naoki Yoshimura; Takashi Kagaya; Makoto Naganuma; Nobuyuki Hida; Mamoru Watanabe; Toshifumi Hibi; Yasuo Suzuki; Soichiro Miura; Ryota Hokari
Journal:  Intest Res       Date:  2016-04-27

Review 9.  Treatment of pregnant women with a diagnosis of inflammatory bowel disease.

Authors:  Sule Poturoglu; Asli Ciftcibasi Ormeci; Ali Erkan Duman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

10.  Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis.

Authors:  Masaki Ujihara; Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Osamu Watanabe; Yutaka Hirayama; Kazuhiro Morise; Keiko Maeda; Masanobu Matsushita; Ryoji Miyahara; Naoki Ohmiya; Yuji Nishio; Takeo Yamaguchi; Jun-Ichi Haruta; Kenji Ina; Hidemi Goto
Journal:  BMC Res Notes       Date:  2013-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.